Predict your next investment

Corporation
HEALTHCARE | Pharmaceuticals / Drugs
supernus.com

See what CB Insights has to offer

Competitors

24

Business Relationships

6

Service Providers

5

Supernus Pharmaceuticals Competitors & Alternatives

24 Competitors

Supernus Pharmaceuticals has 24 competitors. Supernus Pharmaceuticals's competitors are Ology Bioservices, Solasia Pharma, Combinent BioMedical Systems, Sequel Pharmaceuticals, Salix Pharmaceuticals and more.

Latest Funding

Companies

Investment Stage

Total Funding

Mosaic
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

Location

4/12/2021

Acquired

$68.3M

Florida

3/23/2017

IPO

$7.8M

Japan

1/11/2016

Dead

$6.61M

Massachusetts

12/16/2015

Dead

$24.4M

California

4/1/2015

Acq - P2P

New Jersey

6/22/2013

Acq - P2P

$8.7M

Minnesota

5/28/2013

Acq - P2P

$64.01M

New Jersey

1/4/2011

Dead

$105.66M

Maryland

11/22/2010

IPO

$199M

California

4/23/2010

Unattributed VC

$32.26M

New Jersey

Latest Funding

4/12/2021

3/23/2017

1/11/2016

12/16/2015

4/1/2015

6/22/2013

5/28/2013

1/4/2011

11/22/2010

4/23/2010

Companies

Investment Stage

Acquired

IPO

Dead

Dead

Acq - P2P

Acq - P2P

Acq - P2P

Dead

IPO

Unattributed VC

Total Funding

$68.3M

$7.8M

$6.61M

$24.4M

$8.7M

$64.01M

$105.66M

$199M

$32.26M

Mosaic

Location

Florida

Japan

Massachusetts

California

New Jersey

Minnesota

New Jersey

Maryland

California

New Jersey

Supernus Pharmaceuticals Service Providers

5 Service Providers

Supernus Pharmaceuticals has 5 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

IPO

Accounting Firm

Auditor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Subscribe to see more

Associated Rounds

IPO

Subscribe to see more

Subscribe to see more

Provider Type

Accounting Firm

Subscribe to see more

Subscribe to see more

Service Type

Auditor

Subscribe to see more

Partnership data by VentureSource

Supernus Pharmaceuticals Partners & Customers

6 Partners and customers

Supernus Pharmaceuticals has 6 strategic partners and customers. Supernus Pharmaceuticals recently partnered with Stada Arzneimittel on September 9, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

9/15/2020

Licensor

Stada Arzneimittel

Germany

STADA‘s US partner Supernus submits NDA for apomorphine

Britannia Pharmaceuticals Limited 's managing director , Robert Wood , added : `` Submission of this NDA for an apomorphine infusion pump is an important step in the partnership between Supernus Pharmaceuticals , Inc. and STADA Arzneimittel 's Britannia Pharmaceuticals Limited with the goal of offering US patients , caregivers and health professionals a broader range of treatments for Parkinson 's disease . ''

1

6/21/2017

Partner

Shire

Ireland

Subscribe to see more

Subscribe to see more

10

2/16/2016

Licensee

Aequus

United States

Subscribe to see more

Subscribe to see more

10

5/20/2014

Licensee

United Therapeutics

United States

Subscribe to see more

Subscribe to see more

10

9/17/2013

Partner

Catalent

United States

Subscribe to see more

Subscribe to see more

10

Date

9/15/2020

6/21/2017

2/16/2016

5/20/2014

9/17/2013

Type

Licensor

Partner

Licensee

Licensee

Partner

Business Partner

Stada Arzneimittel

Shire

Aequus

United Therapeutics

Catalent

Country

Germany

Ireland

United States

United States

United States

News Snippet

STADA‘s US partner Supernus submits NDA for apomorphine

Britannia Pharmaceuticals Limited 's managing director , Robert Wood , added : `` Submission of this NDA for an apomorphine infusion pump is an important step in the partnership between Supernus Pharmaceuticals , Inc. and STADA Arzneimittel 's Britannia Pharmaceuticals Limited with the goal of offering US patients , caregivers and health professionals a broader range of treatments for Parkinson 's disease . ''

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.